Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Director | Common Stock | 18.2K | $1.61K | $0.09 | Jun 30, 2021 | Direct |
Viking Therapeutics, Inc. | Director | Common Stock, par value $0.00001 per share | 0 | $0 | $80.89 | Oct 25, 2024 | Direct |
Viking Therapeutics, Inc. | Director | Common Stock, par value $0.00001 per share | 0 | $0 | $28.05 | Feb 8, 2024 | Direct |
Viking Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 11K | Oct 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VKTX | Viking Therapeutics, Inc. | Oct 25, 2024 | 3 | -$836K | 4 | Oct 25, 2024 | Director |
VKTX | Viking Therapeutics, Inc. | Feb 8, 2024 | 3 | -$493K | 4 | Feb 8, 2024 | Director |
VKTX | Viking Therapeutics, Inc. | Jan 19, 2024 | 3 | -$442K | 4 | Jan 19, 2024 | Director |
VKTX | Viking Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
VKTX | Viking Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
VKTX | Viking Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | Jun 30, 2021 | 1 | $0 | 4 | Jul 7, 2021 | Director |